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Ketonuria after Fasting may be Related to the Metabolic 
Superiority
Obese individuals are less able to oxidize fat than non-obese individuals. Caloric reduction 
or fasting can detect ketonuria. We investigated the differences of metabolic parameters 
in the presence of ketonuria after a minimum 8 hr fast in a cross-sectional analysis of 
16,523 Koreans (6,512 women and 10,011 men). The relationship between the presence of 
ketonuria of all subjects and prevalence of obesity, central obesity, metabolic syndrome, 
and obesity-related metabolic parameters were assessed. The ketonuria group had lower 
prevalence of obesity, central obesity, and metabolic syndrome than the non-ketonuria 
group. In addition, all metabolic parameters (including body weight, waist circumference, 
blood glucose, high-density lipoprotein, triglyceride, blood pressure, and insulin) were 
favorable in the ketonuria group than in the non-ketonuria group, even after adjustment 
for age, tobacco use, and alcohol consumption. The odds ratios of having obesity (odds 
ratio [OR]=1.427 in women, OR=1.582 in men, P<0.05), central obesity (OR=1.675 in 
women, OR=1.889 in men, P<0.05), and metabolic syndrome (OR=3.505 in women, 
OR=1.356 in men, P<0.05) were increased in the non-ketonuria group compared to the 
ketonuria group. The presence of ketonuria after at least an 8 hr fast may be indicative of 
metabolic superiority. 
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INTRODUCTION
Obesity triggers a variety of metabolic derangements (1-6) that 
include type 2 diabetes, hypertension, dyslipidemia, and car-
diovascular disease (7). In addition, obesity causes chronic in-
flammation (8), which, in turn, results in insulin resistance (9) 
and mitochondrial dysfunction (10). 
  Ketone bodies (acetone, acetoacetate, and b-hydroxybutyr-
ate) increase appreciably in the blood of people on very low 
calorie diet (VLCD) (11, 12). Acetone is a water-soluble volatile 
product of metabolism that can be detected upon exhalation 
and which is excreted in the urine. After a few days of VLCD, fat 
becomes the main source of energy, and VLCD regimens are 
consequently ketogenic (13). One study conducted during a 
Muslim fasting period observed that fasting in excess of 10 hr 
was associated with development of ketosis in normal controls 
after 3-6 days and presence of β-hydroxy butyric and diacetic 
acids in the urine, whereas obese individuals did not show ke-
tosis even after 20 days of a ketogenic diet (14). According to 
this study, obese people did not readily develop ketosis and ke-
tonuria, however, it was clear that the level of ketone bodies in 
the blood depended on the balance between their rate of pro-
duction by the liver and their rate of utilization and excretion. 
Likewise, fat metabolism in obese individuals was different from 
those who were non-obese, as the level of free fatty acid in blood 
after 2 hr fasting was, on average, higher in obese people than in 
normal subjects, with the higher levels perhaps reflecting a pri-
ority for fat metabolism rather than carbohydrate metabolism 
in the obese (15, 16). From these basic metabolic aspects, a low 
carbohydrate ketogenic diet shows the effective results of weight 
reduction (17) and so remains in wide clinical use. While numer-
ous studies have been concerned with the effect of a low carbo-
hydrate ketogenic diet on body weight reduction of obese sub-
jects, little is known of the metabolic differences after fasting in 
the healthy general population. For example, little information 
exists concerning the metabolic differences, if any, related to 
fasting in those with ketonuria and those without, and concern-
ing the relationship between ketonuria and metabolic parame-
ters and the prevalence of obesity, central obesity, and metabol-
ic syndrome. The present cross-sectional study of over 16,000 
Koreans addressed these shortcomings. 
 
MATERIALS AND METHODS
Study design
The study was cross-sectional in design and used the data of a Joo N-S, et al.  •  Ketonuria and Metabolic Superiority 
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Health Promotion Center in Suwon, South Korea. The preva-
lence of obesity, central obesity, and metabolic syndrome ac-
cording to the presence of ketonuria at least 8 hr after fasting 
was evaluated before an annual health check-up. 
Study data
Data from self-administered questionnaires completed by 16,523 
Korean (6,512 women and 10,011 men) prior to a routine health 
check-up in a Health Promotion Center in Suwon, Korea, dur-
ing 2008 was used. We analyzed all adult subjects from twenties 
to fifties in their ages. We excluded the data of over sixties in their 
ages, because of inappropriate sample size and there were no 
pregnant women enrolled in this study. Also, the subsequent 
health test results of urine analysis, anthropometry (body weight, 
waist circumference, and body mass index; BMI), metabolic 
markers such as blood pressure, fasting sugar, triglyceride, high-
density lipoprotein (HDL), and lifestyle information including 
history of tobacco use and alcohol consumption were included. 
Anthropometry and laboratory test
Routine health examination was done after an overnight fast 
(minimum 8 hr). The height and body weight of the participants 
were measured while they wore light clothing without shoes. 
Weight was measured to the nearest 0.1 kg, and height was mea-
sured to the nearest centimeter. BMI was calculated as the weight 
divided by height squared (kg/m
2). Trained nurses in the Health 
Promotion Center measured the waist circumference between 
the lower rib and the iliac crest (18) and electrically measured 
blood pressure after the participants had been at rest for at least 
15 min using a model TM-2655P apparatus (PMS Instruments, 
Tokyo, Japan). The body composition of each participant was 
analyzed using the Body Impedance Analysis, In body 4.0 soft-
ware (Biospace, Seoul, Korea). Additionally, all of the subjects 
underwent automated blood testing using a TBA-200FR appa-
ratus (Toshiba, Tokyo, Japan); measurements included standard 
enzymatic measurements of total cholesterol (TC), high-densi-
ty lipoprotein cholesterol (HDLC), triglycerides (TG), and fast-
ing glucose (FG) in fresh serum samples.
Urine ketone body detection
The presence of ketonuria was assessed in urine using Uropap-
er (US-3100R; Eiken Chemical, Tokyo, Japan). Acetoacetic acid, 
acetone, and 3-hydroxy butyrate are three ketone bodies found in 
normal individuals. Under certain circumstances, these ketone 
bodies are found by lipolysis, which can be detected in urine by 
the appearance of a purple color upon addition of sodium ni-
troprusside to the collected urine, due to the presence of ketone 
bodies (a positive result). Ketonuria results are typically ranked 
on a three-point scale with respect to ketone body concentra-
tion: 1+ (10 mg/dL), 2+ (30 mg/dL), and 3+ (80 mg/dL). Pres-
ently, only a qualitative positive result was determined. 
Definitions of obesity, central obesity and metabolic 
syndrome
Obesity was defined as a BMI ≥25 kg/m
2 and central obesity was 
defined as a waist circumference ≥90 cm for men and ≥85 cm 
for women. The definitions were consistent with the 2006 Kore-
an Society of Study of Obesity guidelines (19). The NCEP-ATP III 
guidelines (20) were used to define metabolic syndrome, which 
consisted of central obesity (waist circumference ≥90 cm for men 
and ≥85 cm for women), blood pressure ≥130/80 mmHg, TG 
≥150 mg/dL, FG ≥110 mg/dL, and low HDLC (men <40 mg/dL, 
women <50 mg/dL). According to the NCEP-AP III guidelines, 
individuals with more than three of the aforementioned values 
that were abnormal were defined as having metabolic syndrome. 
Statistical analyses
Baseline characteristics were descriptively compared to those 
of the entire subjects. Chi-square testing was done to compare 
the prevalence of obesity, central obesity, and metabolic syn-
drome. Independent t test was used to compare the metabolic 
parameters in the two groups and also ANCOVA test was done 
to evaluate metabolic difference after adjustment for age, tobac-
co use, and alcohol consumption. Finally, logistic regression 
analysis was done to determined the odds ratios (ORs) of obe-
sity, central obesity, and metabolic syndrome of non- ketonuria 
individuals compared to those with ketonuria. Statistical analy-
ses were done using SPSS version 11.5 software (SPSS, Chicago, 
IL, USA). All significant P values were <0.05. 
Table 1. Baseline characteristics of study subjects
Variables  Women (n=6,512)  Men (n=10,011)
Age (yr) 41.78±8.26 43.58±7.41
Weight (kg) 56.9±7.8 71.6±9.8
BMI (kg/m
2) 22.6±3.0 24.4±2.8
WC (cm) 79.2±8.2 84.3±1.5
HDL (mg/dL)   58.3±12.9   49.1±11.4
FBS (mg/dL)   90.5±14.3   97.4±20.4
TG (mg/dL)   83.8±55.5 138.0±98.8
s-BP (mmHg) 113.5±14.1 120.8±13.5
d-BP (mmHg)   72.6±10.4   80.8±10.6
Insulin (µIU)   7.3±4.5   8.2±5.4
HOMA-IR   1.80±1.32   2.13±1.60
Uric acid   4.0±0.8   5.8±1.2
Obesity (%) 19.2 40.8
CO (%) 24.6 23.4
MS (%)   8.3 17.1
u-ketone (%) 11.8   6.8
All values are mean±standard deviation.
BMI, body mass index; WC, waist circumference; HDL, high-density lipoprotein; FBS, 
fasting blood sugar; TG, triglyceride; s-BP, systolic blood pressure; d-BP, diastolic 
blood pressure; HOMA-IR, homeostasis model assessment-insulin resistance; Obesity, 
prevalence of obesity in this study subjects; CO, prevalence of central obesity in this 
study subjects; MS, prevalence of metabolic syndrome by NCEP-ATP III in this study 
subjects; u-ketone, prevalence of keteonuria after overnight fasting at least eight 
hours.Joo N-S, et al.  •  Ketonuria and Metabolic Superiority 
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Ethics statement
All examinees agreed to the use of their health check-up results 
and the Institutional Review Board of Ajou University Hospital 
approved the study (AJIRB-MED-OBS-09-147).
RESULTS
The study involved 16,523 Koreans (6,512 women and 10,011 
men) whose mean age was 40–49-yr. Mean anthropometry and 
metabolic parameters in this study data were not seriously de-
teriorated. The prevalence of obesity, central obesity, and meta-
bolic syndrome in women was 19.2%, 24.6%, 8.3%, respectively 
and the respective percentages in men were 40.8%, 23.4%, 17.1%. 
The rate of ketonuria in women was 11.8% and 6.8% in men 
(Table 1). 
  Comparisons of the prevalence of obesity, central obesity, and 
metabolic syndrome revealed lower rates of all parameters in 
subjects with ketonuria than in the non-ketonuria group (Fig. 1). 
The prevalence of obesity, central obesity, and metabolic syn-
drome was also compared in those subjects in the age range of 
20–59-yr; results were lower in the ketonuria group than in the 
non-ketonuria group. In some generation, significant differenc-
%
%
20.3
41.8
25.9
23.9
9.1
17.4 11.9
27.5
Prevalence in women Prevalence in men
17.6
16.5
2.3
13.3
  OB  CO  MS   OB  CO  MS
30
25
20
15
10
5
0
45
40
35
30
25
20
15
10
5
0
u-ketone (-) u-ketone (+)
Fig. 1. Prevalence of obesity, central obesity, and metabolic syndrome according to the presence of ketonuria in all subjects. This figure is representing the prevalence of obesity, 
central obesity, and metabolic syndrome according to the presence of ketonuria and all showed statistically significant difference (P<0.05) in both genders. 
OB, obesity (body mass index ≥25.0 kg/m
2); CO, central obesity (men ≥90 cm, women ≥85 cm); MS, metabolic syndrome followed by NCEP-ATP III.
Fig. 2. Prevalence of obesity, cen-
tral obesity, and metabolic synd-
rome in each generation. This fig-
ure shows the prevalence of obe-
sity, central obesity, and metabolic 
syndrome from the 20th to the 50th 
in both genders according to keto-
nuria under overnight fasting con-
dition, which may represent that 
all subjects with ketonuria under 
fasting condition could be more 
metabolic benefit compared to the 
non-ketonuria. 
*P<0.05 in each generation in both 
genders.
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Table 3. Odds ratios of having obesity, central obesity, and metabolic syndrome in the 
non-detection of urinary ketone group compared to the detection of urinary ketone 
group
Women (95% CI) Men (95% CI)
OB 1.427 (1.157-1.760) 1.582 (1.274-1.964)
CO 1.675 (1.330-2.109) 1.889 (1.589-2.246)
MS 3.505 (2.031-6.050) 1.356 (1.052-1.748)
This table shows odds ratios of having obesity, central obesity, and metabolic synd-
rome in the non-detection of urinary ketone group compared to the detection of uri-
nary keteone group in both genders using logistic regression analysis was done after 
age-adjustment. All P values of odds ratios were <0.05.
OB, obesity (body mass index ≥25.0 kg/m
2); CO, central obesity (waist circumference; 
men ≥90 cm, women ≥85 cm); MS, metabolic syndrome followed by NCEP-ATP III.
es were detected in both genders by the presence of fasting ke-
tonuria (Fig. 2).
  Comparisons of metabolic parameters in both genders also 
showed that almost all metabolic parameters including body 
weight, BMI, waist circumference, HDL, glucose, TG, blood pres-
sure, and insulin level were significantly better in the ketonuria 
group than in non-ketonuria group before and after adjustment 
for age, tobacco use, and alcohol consumption (Table 2). 
  ORs of obesity, central obesity, and metabolic syndrome in 
the non-ketonuria group compared to the ketonuria group were 
evaluated after age adjustment. ORs in the non-ketonuria group 
were elevated in obesity (OR=1.427 in women, OR=1.582 in men), 
central obesity (OR=1.675 in women, OR=1.889 in men), and 
metabolic syndrome (OR=3.505 in women, OR=1.356 in men) 
compared to the ketonuria group (Table 3). 
DISCUSSION
In the present study, individuals with ketonuria fared better met-
abolically than those in the non-ketonuria group regardless of 
gender or age. There was lower prevalence of obesity, central 
obesity, and metabolic syndrome in the ketonuria group than 
in the non-ketonuria group. In addition, various metabolic pa-
rameters such as HDL, TG, FG, insulin including body weight, 
BMI, and waist circumference showed better values. Moreover, 
the ORs of having obesity, central obesity, and metabolic syn-
drome were lower in those with ketonuria than in the non-keto-
nuria group. 
  Many studies have focused on the ketogenic effect of a low 
carbohydrate diet on weight reduction and metabolism. A me-
ta-analysis of five trials with 447 participants and a 1-yr trial in-
volving 311 obese women suggested that a low-carbohydrate 
diet is a feasible alternative to a low-fat diet for weight loss, and 
may also have favorable metabolic effects (21, 22). Another study 
that evaluated a low-carbohydrate, high-protein, high-fat diet 
(Atkins diet) and a low-calorie, high-carbohydrate, low-fat diet 
(conventional diet) found that the low-carbohydrate diet result-
ed in more weight loss than the conventional diet after the first 
six months, but the differences were not significant after one 
year (23). 
  Concerning the effect of a low-carbohydrate, ketogenic diet 
on nonalcoholic fatty liver disease, a small pilot study reported 
that four of five post-treatment liver biopsies showed histologic 
improvements in steatosis, inflammatory grade, and fibrosis af-
ter 3 months (24). Another study reported that Mediterranean 
and low-carbohydrate diets may be effective alternatives to a 
low-fat diet, with more favorable effects on lipids and glycemic 
control (25). One possible explanation for reduced body weight 
with a low-carbohydrate diet might be activated fatty acid oxi-
dation (26). 
  The relationship between ketonuria and metabolic parame-
ters in the general population after an overnight fast of at least 8 
hr is ill-understood. The present cross-sectional observational 
study indicates that, similar to a low-carbohydrate diet for obese 
Table 2. Comparisons of metabolic parameters according to urinary ketone in both genders
Variables
Women (n=6,512) Men (n=10,011)
u-ketone (-) u-ketone (+) P u-ketone (-) u-ketone (+) P
Age (yr) 42.0±8.2 39.8±8.0 <0.001 43.6±7.3 43.1±7.8 0.080
Weight (kg) 57.2±7.9 55.1±7.0 <0.001* 71.8±9.7 68.4±9.8 <0.001*
BMI (kg/m
2) 22.7±3.0 21.8±2.6 <0.001* 24.5±2.8 23.5±2.9 <0.001*
WC (cm) 79.5±8.2 76.8±7.7 <0.001* 84.4±7,4 81.9±7.9 <0.001*
HDL (mg/dL)
† 57.8±12.8 62.1±13.4 <0.001* 48.8±11.2 52.9±12.9 <0.001*
FBS (mg/dL) 90.9±13.6 87.6±18.8 <0.001* 97.0±17.8          102.42.0 <0.001*
TG (mg/dL)
† 87.8±56.8 54.0±32.6 <0.001* 140.9±97.4 97.6±109.7 <0.001*
s-BP (mmHg) 113.9±14.2 111.0±12.9 <0.001* 120.9±13.5 118.8±13.3 <0.001*
d-BP (mmHg) 72.8±10.5 71.3±9.8 <0.001 80.9±10.6 79.5±10.7 0.001*
Insulin (µIU) 7.5±4.5 6.2±4.3 0.016* 8.4±5.5 6.4±3.8 <0.001*
HOMA-IR 1.85±1.32 1.56±1.33 0.055 2.16±1.60 1.86±1.60 0.108
UA (mg/dL) 3.9±0.8 4.0±0.9 0.004 5.8±1.2 5.8±1.2 0.398
All values are mean±standard deviation.
P values were from independent t test in both genders.
*were marked on the P values were <0.05 after ANCOVA test after age, cigarette smoking, alcohol drinking adjustment; 
†was from non-parametric test (Mann-Whitney U test).
BMI, body mass index, calculated from body weight (kg)/height (m
2); WC, waist circumference; HDL, high-density lipoprotein; FBS, fasting blood sugar; TG, triglyceride; s-BP, 
systolic blood pressure; d-BP, diastolic blood pressure; HOMA-IR, homeostasis of measurement assessment-insulin resistance; UA, uric acid.Joo N-S, et al.  •  Ketonuria and Metabolic Superiority 
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subjects, some (but not all) individuals display ketonuria after 
fasting. This may be a consequence of the oxidation of fat (lipol-
ysis) in those with a healthy fat metabolism. Presently, only 8.8% 
of the total subjects (11.8% in women, 6.8% in men) showed ke-
tonuria after simple fasting. This may mean that ketonuria is not 
a common phenomenon in modern people, and that the capa-
bility to oxidize fat decreases upon fasting, resulting in an abnor-
mal fat metabolism. In our results, metabolic parameters such 
as BMI, waist circumference, HDL, glucose, TG, blood pressure, 
and insulin level were significantly lower in the ketonuria group 
than in the non-ketonuria group. Also, the OR of obesity, central 
obesity, and metabolic syndrome were higher in the non-keto-
nuria group than in the ketonuria group, even though the study 
data was cross-sectional. From this, we deduce that individuals 
with ketonuria have metabolic benefits under simple fasting, 
which may mean that ketonuria is associated with a higher fat 
oxidation ability than in the absence of ketonuria. This sugges-
tion remains speculative, however, since fat oxidation capacity 
or ability was not directly measured. 
  This study has several limitations. The first is its cross-section-
al observational nature. Causality could not be drawn from this 
study. Our study subjects represented one ethnic group and were 
a small number of people from one region, making generalized 
of the results impossible. We could not adjust many possible 
confounding factors such as regular exercise time and frequen-
cy, use of some medications, total fasting time and other meta-
bolic parameter such as free fatty acid. Of these confounding 
factors, individual fasting time for the examination could be the 
most important, because ketonuria could be detected with in-
creasing fasting time. Despite the shortcomings, the present 
study demonstrates that the presence of ketonuria can have the 
relationship of metabolic superiority in some sense. 
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